<p>The National Institutes of Health has released comprehensive new COVID-19 treatment guidelines, including evidence-based direction on drug therapies.</p>



<p>The <a href="https://covid19treatmentguidelines.nih.gov/introduction/">guideline web page</a> is a &ldquo;living document,&rdquo; which will change as new information and evidence emerges, the agency announced Tuesday. The recommendations were developed by a panel of physician experts and cover the following:</p>



<ul><li>Therapies currently in use for COVID-19, namely antivirals and host modifiers and immune-based therapies. Notably, the panel recommends against combined treatment with hydroxychloroquine plus azithromycin due to its potential effect on the heart.</li><li>Evaluating and stratifying patients based on their infection risk and illness severity.&nbsp;</li><li>Best practices for managing different stages of infection.</li><li>The use of related medications. These include statins, corticosteroids, non-steroidal anti-inflammatory drugs, as well as ACE inhibitors and ARBs.</li><li>Considerations for clinicians caring for the most critically ill hospitalized patients.</li></ul><p>The post <a rel="nofollow" href="https://www.mcknights.com/news/clinical-news/nih-releases-covid-19-treatment-guidelines-warns-against-drug-combo/">NIH releases COVID-19 treatment guidelines, warns against drug combo</a> appeared first on <a rel="nofollow" href="https://www.mcknights.com/">McKnight's Long Term Care News</a>.</p>